In children with multiple sclerosis, teriflunomide tempers lesion growth
A phase 3 clinical trial tested the safety and efficacy of teriflunomide, an oral immunomodulatory drug, in children with multiple sclerosis. Although the medication did not prevent disease relapses to a greater extent than placebo, the option for some…
Shrinking qubits for quantum computing with atom-thin materials
Current approaches to create superconducting qubits for quantum computers yield chips that are substantially larger than those found in classical computers. To shrink things down, researchers have taken advantage of atomically thin, 2D materials to con…
Bringing 400-million-year-old fossilized armored worms to ‘virtual’ life
Scientists have documented the discovery of two new species of fossilized armored worms in Australia — Lepidocoleus caliburnus and Lepidocoleus shurikenus — dating from about 400 million years ago. Then, using the micro-CT imaging capabilities of the…
Altered DNA repair and DNA damage in neurodegenerative conditions
Researchers have confirmed a link between altered DNA repair and increased DNA damage associated with spinocerebellar ataxia type 7 (SCA7), a debilitating, sometimes deadly neurodegenerative condition causing movement disorders. Their work also reveale…
Quanta Services Inc (PWR) FY 2021 Earnings Call Transcript
PWR earnings call for the period ending November 30, 2021.
Your Concise New York Art Guide for December 2021
Your list of must-see, fun, insightful, and very New York art events this month.
Your Concise Los Angeles Art Guide for December 2021
Your list of must-see, fun, insightful, and very Los Angeles art events this month.
Self-Portrait as Future
When looking at images from the golden age of Sudanese photography, I was reminded to listen as much as look.
The Poetics of an Invisible Market
“I’m making a financial instrument as an artwork. That’s the new reality.” She stares unwavering into the distance. “What is existence on the blockchain? Does an NFT exist?”
Why Beyond Meat Was Tanking on Tuesday
A new analyst note isn’t going down well at all with investors.